Studies have shown that Nasaleze significantly reduces the symptoms of allergic rhinitis and hay fever caused by pollen and dust mites. These studies will be presented by Professor Jean Emberlin at a conference on 23 May 2007. This body of evidence will also show that Nasaleze has the ability to stop a sneezing fit in minutes, providing effective treatment for the annual bout of hay fever. Rhinitis is a good example of how mites can cause and trigger chronic allergic disease. Initial contact with mite droppings may have resulted in annoying symptoms of repeated sneezing or a constant runny nose. Further exposure can lead to a permanently stuffy or 'bunged-up' nose and losing the sense of smell. Once chronic symptoms such as these become established, it is difficult to tell when further allergen exposure takes place because the allergic reactions are joined in one long symptom. Chronic rhinitis is clinically recognized as a risk factor for the development of allergic asthma. Prof Emberlin, who runs the UK National Pollen and Aerobiology Research Unit believes that Nasaleze has the ability to help long suffering patients. "Using a natural product to combat one of the most common ailments is scientifically very exciting. The results from our studies clearly show that the plant cellulose used in Nasaleze have a significant positive effect on subjects who were diagnosed with chronic rhinitis." For two of the studies being presented Prof Emberlin will only be presenting initial results as the papers will be published in due course. Nasaleze's efficacy* is equal to or greater than some of the biggest selling allergy interventions and is a unique natural product that offers a viable alternative to the steroids and antihistamines currently on the market. Nasaleze is a clinically proven, unique, natural nasal powder spray that works with your own body's defense mechanism to strengthen the resistance to airborne allergens that are inhaled through your nose. It acts as a natural barrier to airborne allergens, forming a colourless, mucus-like gel lining in the nasal tract that acts as a filter for dust and germs. Nasaleze is a unique blend of cellulose with peppermint and meets both the highest purity and safety standards, being a natural plant based extract. Nasaleze is available from leading pharmacies and good health food stores. Price £6.95 Nasaleze is a Class 1 Medical Device, as classified by the EU and other Countries worldwide, and falls within the safest of all four categories of Medical Device. There is no active ingredient in Nasaleze and therefore it cannot be a pharmaceutical product. The Nasaleze story The Nasaleze story all began one day in 1990. Mike James was working in a factory making cosmetic facemasks for a well-known British healthcare product retailer using a number of ingredients. Mike noticed that despite there usually being clouds of white powder in the air nobody ever sneezed. At the same time his teenage son was suffering terribly from allergies, sneezing almost constantly. Mike's wife asked he do something about their son's condition, under pressure Mike's mind was cast back to the clouds of white powder in the factory. The following day he brought home some of this (cellulose) powder and suggested his sneezing son should 'sniff' some of the powder off the back of his hand. The sneezing stopped in a matter of seconds and all the other symptoms subsided over the next few minutes. Mike was astonished by the effect and realized he had discovered something. Mike immediately set about researching and developing his idea, including creating the unique and patented special delivery system. After the initial research proved encouraging Mike was ready to bring his invention to market. However, the Medicines Control Agency (as it was known at the time) had other ideas, claiming that Mike was illegally producing a pharmaceutical product and that he should stop immediately. Undeterred, Mike went about proving that his product was natural and not a drug. In order to get the Medicines Control Agency to approve Mike invoked the help of a political friend, Sir Teddy Taylor MP. In the UK there is a weekly opportunity for a Member of Parliament to ask the Prime Minister a question in the House of Commons, known as Prime Minister's Question Time. Upon Mike's request, Sir Teddy Taylor asked the Prime Minister why Mr. James was being prevented from manufacturing and selling his natural allergy product. After this the Medicines Control Agency were forced to look into the issue in greater detail and came to the conclusion that Nasaleze was in fact a low risk product, not a drug and that it should be registered as a Class 1 Medical Device under EU Directive 93/42/EEC. Nasaleze is now distributed in over 30 countries worldwide and is gaining respect from the Medical Community after successive and successful clinical studies. Reference *P. Josling, S. Steadman, Use of Cellulose Powder for the Treatment of Seasonal Allergic Rhinitis, 2003